Jean Pierre Bleuse

Multicenter Phase II Trial of Neoadjuvant Therapy With Trastuzumab, Docetaxel, and Carboplatin for Human Epidermal Growth Factor Receptor-2–Overexpressing Stage II or III Breast Cancer: Results of the GETN(A)-1 Trial

Bruno Coudert, Rémy Largillier, Laurent Arnould et al. · Journal of Clinical Oncology · 2007 · 132 citations · Full text

Cetuximab Plus FOLFIRINOX (ERBIRINOX) as First-Line Treatment for Unresectable Metastatic Colorectal Cancer: A Phase II Trial

Eric Assénat, Françoise Desseigne, Simon Thézenas et al. · The Oncologist · 2011 · 80 citations · Full text

Randomized phase <scp>II</scp> study of danusertib in patients with metastatic castration‐resistant prostate cancer after docetaxel failure

Hielke J. Meulenbeld, Jean Pierre Bleuse, Elio M. Vinci et al. · British Journal of Urology · 2012 · 76 citations